How NF-κB signaling in ABC DLBCL is impaired by PI3Kβ/δ blockade is not well understood, but direct activation of the IKK complex by AKT has been proposed [40, 41]. The gene discussed is AKT1; the disease is diffuse large B-cell lymphoma.